Didier Lebrec

Active 1978–2025

99
Papers
20,024
Citations
85
h-index
98
i10-index

Citations

Citations per year for Didier Lebrec1960: 1 citations1978: 1 citations1979: 4 citations1981: 9 citations1982: 12 citations1983: 22 citations1984: 21 citations1985: 29 citations1986: 51 citations1987: 41 citations1988: 34 citations1989: 36 citations1990: 37 citations1991: 39 citations1992: 32 citations1993: 21 citations1994: 18 citations1995: 38 citations1996: 37 citations1997: 35 citations1998: 51 citations1999: 76 citations2000: 50 citations2001: 91 citations2002: 99 citations2003: 83 citations2004: 103 citations2005: 123 citations2006: 124 citations2007: 127 citations2008: 178 citations2009: 134 citations2010: 156 citations2011: 108 citations2012: 201 citations2013: 147 citations2014: 162 citations2015: 154 citations2016: 136 citations2017: 106 citations2018: 100 citations2019: 289 citations2020: 320 citations2021: 234 citations2022: 152 citations2023: 121 citations2024: 182 citations2025: 67 citations2026: 3 citations1961–1977: no citations, so these years are not shown1980: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,123 citing papers, 22.2% of this breakdownFrance: 476 citing papers, 9.4% of this breakdownUnited Kingdom: 402 citing papers, 8% of this breakdownItaly: 350 citing papers, 6.9% of this breakdownSpain: 344 citing papers, 6.8% of this breakdownGermany: 282 citing papers, 5.6% of this breakdownChina: 241 citing papers, 4.8% of this breakdownCanada: 200 citing papers, 4% of this breakdownSwitzerland: 126 citing papers, 2.5% of this breakdownIndia: 122 citing papers, 2.4% of this breakdownBelgium: 114 citing papers, 2.3% of this breakdownNetherlands: 99 citing papers, 2% of this breakdown
0%22.2%Other 23.1%

Fields

  • Medicine90.5%
  • Biochemistry, Genetics and Molecular Biology4.5%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • Immunology and Microbiology0.8%
  • Psychology0.7%
  • Health Professions0.7%
  • Other1.7%

Topics

  • Liver Disease and Transplantation20.3%
  • Liver Disease Diagnosis and Treatment14.1%
  • Organ Transplantation Techniques and Outcomes7.3%
  • Pulmonary Hypertension Research and Treatments6%
  • Drug-Induced Hepatotoxicity and Protection1.9%
  • Hepatocellular Carcinoma Treatment and Prognosis1.8%
  • Other48.6%

Coauthors

All papers

Open in search
  1. Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2018 cited by 171

  2. Deleterious Effects of Beta-Blockers on Survival in Patients With Cirrhosis and Refractory Ascites†,‡

    Authors: , , , , , , , - Hepatology 2010 cited by 522

  3. Deleterious Effects of β-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension

    Authors: , , , , , , - Gastroenterology 2006 cited by 311

  4. Severe sepsis in cirrhosis†

    Authors: , , , , - Hepatology 2009 cited by 446

  5. Autophagy in liver diseases

    Authors: , , , , , - Journal of Hepatology 2010 cited by 378

  6. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study

    Authors: , , , , , , , , , , , - Hepatology 2003 cited by 354

  7. Meta-analyses of FibroTest diagnostic value in chronic liver disease

    Authors: , , , , , , , , , , , , , , - BMC Gastroenterology 2007 cited by 318

  8. Clinical classification of pulmonary hypertension

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2004 cited by 1,902

  9. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients

    Authors: , , , , , , , - Gut 2002 cited by 309

  10. Portopulmonary Hypertension: Survival and Prognostic Factors

    Authors: , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2008 cited by 240

  11. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites

    Authors: , , , , , , - Liver International 2004 cited by 156

  12. A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis

    Authors: , , , , , , , , , , , , , , , - Hepatology 2017 cited by 115

  13. Prospective Comparison of Spleen and Liver Stiffness by Using Shear-Wave and Transient Elastography for Detection of Portal Hypertension in Cirrhosis

    Authors: , , , , , , , , , , , - Radiology 2014 cited by 235

  14. Cardiac hepatopathy: Clinical, hemodynamic, and histologic characteristics and correlations

    Authors: , , , , , , - Hepatology 2003 cited by 234

  15. Prednisolone With vs Without Pentoxifylline and Survival of Patients With Severe Alcoholic Hepatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA 2013 cited by 206

  16. The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study

    Authors: , , , , , , , , , - Liver International 2009 cited by 182

  17. Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis

    Authors: , , , - New England Journal of Medicine 1981 cited by 518

  18. Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics

    Authors: , , , - Gastroenterology 1991 cited by 497

  19. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial

    Authors: , , , , , , , , , - Journal of Hepatology 1996 cited by 447

  20. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

    Authors: , , , , , , , , , - Hepatology 2007 cited by 275

  21. Early Administration of Vapreotide for Variceal Bleeding in Patients with Cirrhosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2001 cited by 241

  22. Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta‐analysis

    Authors: , , , , , , , , , - Liver International 2005 cited by 131

  23. In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C

    Authors: , , , , , , , , , , , , , , , , - The Journal of Pathology 2010 cited by 124

  24. Relationship between the Fibrotest and portal hypertension in patients with liver disease

    Authors: , , , , , , , , - Alimentary Pharmacology & Therapeutics 2007 cited by 85